Phacilitate Leaders Forum

29TH - 30TH SEPTEMBER 2020



Katherine Cohen

Katherine Cohen

Venture Partner, Panacea Venture
Katherine Cohen joined Panacea Venture in 2018 and is based in Vienna, Austria. She has over 25 years of experience in the biotech and pharmaceutical industry and is a certified European Patent Attorney. Before joining Panacea Venture, Dr. Cohen served as CEO at Hookipa Biotech AG (now Hookipa Pharma Inc.), where she was responsible for the company formation and Series A and B venture financing, and under her leadership Hookipa grew from a research start-up to a clinical stage company. Prior to Hookipa, Dr. Cohen was Senior Vice President for Corporate and Business Development at Intercell AG (now Valneva SE) where she played an important role in the growth of the company from a start-up to a successful public and commercial stage enterprise. Prior to her biotech entrepreneurial career, Dr. Cohen worked in academic research and industrial development at Sandoz/VIRCC. 

Dr. Cohen earned her Ph.D. in Biology at the City University of New York and B.S. from Wuhan University in China. 
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd